InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Silver Gabrielle Alison, 董事. Officer active across 1 company, notably Opiant Pharmaceuticals, INC.. In total, 5 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €32k. Activity tracked since 13 May 2021. The latest transaction was filed on 2 March 2023 (Disposition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Silver Gabrielle Alison
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
21,343 股@ US$20.0091.4% 占其流量Common StockSEC:0001385508-23-000077:0
2,000 股0Common StockSEC:0001385508-22-000082:0
2,500 股@ US$13.28884.0% 占其流量Common StockSEC:0001385508-22-000062:0
标准退出：2022年8月14日 (T+90)
2,000 股0Common StockSEC:0001385508-21-000085:0
365 股@ US$10.000.7% 占其流量Common StockSEC:0001385508-21-000071:0
5 条申报中的 5 条
About Silver Gabrielle Alison
Gabrielle Alison Silver is a Director at Opiant Pharmaceuticals, Inc. She actively participates in board discussions, bringing her expertise in the pharmaceutical field. Gabrielle contributes to the company's strategy and oversight of product development initiatives.
